LPL Financial’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$395K Buy
299,597
+25,350
+9% +$45.4K ﹤0.01% 4972
2025
Q4
$513K Buy
274,247
+60,124
+28% +$116K ﹤0.01% 4690
2025
Q3
$274K Buy
214,123
+37,581
+21% +$50.9K ﹤0.01% 5121
2025
Q2
$219K Sell
176,542
-7,261
-4% -$8.38K ﹤0.01% 5023
2025
Q1
$217K Sell
183,803
-1,419
-0.8% -$2.18K ﹤0.01% 4809
2024
Q4
$339K Sell
185,222
-10,291
-5% -$20.1K ﹤0.01% 4412
2024
Q3
$332K Sell
195,513
-5,929
-3% -$9.74K ﹤0.01% 4343
2024
Q2
$276K Buy
201,442
+20,790
+12% +$42K ﹤0.01% 4339
2024
Q1
$677K Buy
180,652
+477
+0.3% +$2.79K ﹤0.01% 3516
2023
Q4
$1.77M Buy
180,175
+4,844
+3% +$39.6K ﹤0.01% 2521
2023
Q3
$1.46M Buy
175,331
+20,386
+13% +$233K ﹤0.01% 2578
2023
Q2
$2.06M Sell
154,945
-5,557
-3% -$67.5K ﹤0.01% 2221
2023
Q1
$1.86M Sell
160,502
-44,664
-22% -$444K ﹤0.01% 2205
2022
Q4
$1.68M Sell
205,166
-8,766
-4% -$75.5K ﹤0.01% 2207
2022
Q3
$1.24M Buy
213,932
+12,447
+6% +$71.4K ﹤0.01% 2365
2022
Q2
$891K Buy
201,485
+70,255
+54% +$427K ﹤0.01% 2666
2022
Q1
$1.19M Buy
131,230
+30,597
+30% +$352K ﹤0.01% 2461
2021
Q4
$2.06M Buy
100,633
+21,035
+26% +$508K ﹤0.01% 2068
2021
Q3
$2.03M Buy
79,598
+178
+0.2% +$5.27K ﹤0.01% 2025
2021
Q2
$2.78M Buy
79,420
+35,812
+82% +$1.04M ﹤0.01% 1733
2021
Q1
$1.45M Sell
43,608
-87
-0.2% -$3.04K ﹤0.01% 2085
2020
Q4
$1.13M Buy
43,695
+20,985
+92% +$357K ﹤0.01% 2086
2020
Q3
$224K Buy
22,710
+3,085
+16% +$17.8K ﹤0.01% 3124
2020
Q2
$68K Buy
+19,625
New +$66.8K ﹤0.01% 3330
2019
Q3
Sell
-28,350
Closed -$172K 3357
2019
Q2
$172K Buy
28,350
+8,000
+39% +$56.1K ﹤0.01% 3064
2019
Q1
$147K Buy
+20,350
New +$147K ﹤0.01% 3016
2018
Q4
Sell
-23,095
Closed -$125K 3199
2018
Q3
$125K Buy
23,095
+2,405
+12% +$10.3K ﹤0.01% 3095
2018
Q2
$73K Buy
+20,690
New +$57.4K ﹤0.01% 3126
2017
Q4
Sell
-40,350
Closed -$212K 3059
2017
Q3
$212K Buy
40,350
+2,750
+7% +$11.8K ﹤0.01% 2630
2017
Q2
$134K Buy
+37,600
New +$152K ﹤0.01% 2678
2017
Q1
Sell
-11,450
Closed -$50K 2771
2016
Q4
$50K Hold
11,450
﹤0.01% 2638
2016
Q3
$101K Buy
+11,450
New +$95.7K ﹤0.01% 2533

Other funds holding PACB